
Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Global Market Report 2025
Description
Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on chimeric antigen receptor-natural killer (car-nk) cell therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for chimeric antigen receptor-natural killer (car-nk) cell therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The chimeric antigen receptor-natural killer (car-nk) cell therapy market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Type: Cytokine Therapy; Adoptive Natural Killer (NK) Cell Therapy; Genetically Engineered Natural Killer Cell Therapy; Other Types
2) By Cell Source: Peripheral Blood-Derived Natural Killer Cells; Cord Blood-Derived Natural Killer Cells; Induced Pluripotent Stem Cell (iPSC)-Derived Natural Killer Cells; Natural Killer Cell Lines
3) By Application: Solid Tumors; Hematological Malignancies; Other Applications
4) By End User: Hospitals; Cancer Research Institutes; Biotechnology And Pharmaceutical Companies
Subsegments:
1) By Cytokine Therapy: Interleukin Therapy; Interferon Therapy; Colony Stimulating Factor Therapy; Tumor Necrosis Factor Therapy
2) By Adoptive Natural Killer Cell Therapy: Autologous Natural Killer Cell Therapy; Allogeneic Natural Killer Cell Therapy; Expanded Natural Killer Cell Therapy; Activated Natural Killer Cell Therapy
3) By Genetically Engineered Natural Killer Cell Therapy: Chimeric Antigen Receptor Natural Killer Cell Therapy; T Cell Receptor Engineered Natural Killer Cell Therapy; Gene Edited Natural Killer Cell Therapy; Cytokine Gene Modified Natural Killer Cell Therapy
4) By Other Types: Combination Therapy; Immune Checkpoint Inhibitor Therapy; Antibody Dependent Cellular Cytotoxicity Therapy; Oncolytic Virus Therapy
Companies Mentioned: Takeda Pharmaceutical Company Limited; Artiva Biotherapeutics Inc.; Nkarta Inc.; ImmunityBio Inc.; Fate Therapeutics Inc.; Acepodia Inc.; PersonGen BioTherapeutics Inc.; Cartherics Inc.; Century Therapeutics Inc.; Catamaran Bio Inc.; Glycostem Therapeutics Ltd.; ImmuneBridge Co. Ltd.; ONK Therapeutics Inc.; Senti Biosciences Inc.; Wugen Therapeutics Inc.; Chimeric Therapeutics Limited; East Ocyon Bio; Nuwacell Biotechnologies Co. Ltd.; Nkarta Therapeutics Inc.; GICELL Co. Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on chimeric antigen receptor-natural killer (car-nk) cell therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for chimeric antigen receptor-natural killer (car-nk) cell therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The chimeric antigen receptor-natural killer (car-nk) cell therapy market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Type: Cytokine Therapy; Adoptive Natural Killer (NK) Cell Therapy; Genetically Engineered Natural Killer Cell Therapy; Other Types
2) By Cell Source: Peripheral Blood-Derived Natural Killer Cells; Cord Blood-Derived Natural Killer Cells; Induced Pluripotent Stem Cell (iPSC)-Derived Natural Killer Cells; Natural Killer Cell Lines
3) By Application: Solid Tumors; Hematological Malignancies; Other Applications
4) By End User: Hospitals; Cancer Research Institutes; Biotechnology And Pharmaceutical Companies
Subsegments:
1) By Cytokine Therapy: Interleukin Therapy; Interferon Therapy; Colony Stimulating Factor Therapy; Tumor Necrosis Factor Therapy
2) By Adoptive Natural Killer Cell Therapy: Autologous Natural Killer Cell Therapy; Allogeneic Natural Killer Cell Therapy; Expanded Natural Killer Cell Therapy; Activated Natural Killer Cell Therapy
3) By Genetically Engineered Natural Killer Cell Therapy: Chimeric Antigen Receptor Natural Killer Cell Therapy; T Cell Receptor Engineered Natural Killer Cell Therapy; Gene Edited Natural Killer Cell Therapy; Cytokine Gene Modified Natural Killer Cell Therapy
4) By Other Types: Combination Therapy; Immune Checkpoint Inhibitor Therapy; Antibody Dependent Cellular Cytotoxicity Therapy; Oncolytic Virus Therapy
Companies Mentioned: Takeda Pharmaceutical Company Limited; Artiva Biotherapeutics Inc.; Nkarta Inc.; ImmunityBio Inc.; Fate Therapeutics Inc.; Acepodia Inc.; PersonGen BioTherapeutics Inc.; Cartherics Inc.; Century Therapeutics Inc.; Catamaran Bio Inc.; Glycostem Therapeutics Ltd.; ImmuneBridge Co. Ltd.; ONK Therapeutics Inc.; Senti Biosciences Inc.; Wugen Therapeutics Inc.; Chimeric Therapeutics Limited; East Ocyon Bio; Nuwacell Biotechnologies Co. Ltd.; Nkarta Therapeutics Inc.; GICELL Co. Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
250 Pages
- 1. Executive Summary
- 2. Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market Characteristics
- 3. Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market Trends And Strategies
- 4. Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
- 4.1. Supply Chain Impact from Tariff War & Trade Protectionism
- 5. Global Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Growth Analysis And Strategic Analysis Framework
- 5.1. Global Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market Growth Rate Analysis
- 5.4. Global Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Total Addressable Market (TAM)
- 6. Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market Segmentation
- 6.1. Global Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Cytokine Therapy
- Adoptive Natural Killer (NK) Cell Therapy
- Genetically Engineered Natural Killer Cell Therapy
- Other Types
- 6.2. Global Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Peripheral Blood-Derived Natural Killer Cells
- Cord Blood-Derived Natural Killer Cells
- Induced Pluripotent Stem Cell (iPSC)-Derived Natural Killer Cells
- Natural Killer Cell Lines
- 6.3. Global Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Solid Tumors
- Hematological Malignancies
- Other Applications
- 6.4. Global Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Cancer Research Institutes
- Biotechnology And Pharmaceutical Companies
- 6.5. Global Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Sub-Segmentation Of Cytokine Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Interleukin Therapy
- Interferon Therapy
- Colony Stimulating Factor Therapy
- Tumor Necrosis Factor Therapy
- 6.6. Global Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Sub-Segmentation Of Adoptive Natural Killer Cell Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Autologous Natural Killer Cell Therapy
- Allogeneic Natural Killer Cell Therapy
- Expanded Natural Killer Cell Therapy
- Activated Natural Killer Cell Therapy
- 6.7. Global Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Sub-Segmentation Of Genetically Engineered Natural Killer Cell Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Chimeric Antigen Receptor Natural Killer Cell Therapy
- T Cell Receptor Engineered Natural Killer Cell Therapy
- Gene Edited Natural Killer Cell Therapy
- Cytokine Gene Modified Natural Killer Cell Therapy
- 6.8. Global Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Combination Therapy
- Immune Checkpoint Inhibitor Therapy
- Antibody Dependent Cellular Cytotoxicity Therapy
- Oncolytic Virus Therapy
- 7. Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market Regional And Country Analysis
- 7.1. Global Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market
- 8.1. Asia-Pacific Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market
- 9.1. China Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market Overview
- 9.2. China Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market
- 10.1. India Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market
- 11.1. Japan Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market Overview
- 11.2. Japan Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market
- 12.1. Australia Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market
- 13.1. Indonesia Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market
- 14.1. South Korea Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market Overview
- 14.2. South Korea Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market
- 15.1. Western Europe Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market Overview
- 15.2. Western Europe Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market
- 16.1. UK Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market
- 17.1. Germany Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market
- 18.1. France Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market
- 19.1. Italy Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market
- 20.1. Spain Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market
- 21.1. Eastern Europe Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market Overview
- 21.2. Eastern Europe Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market
- 22.1. Russia Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market
- 23.1. North America Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market Overview
- 23.2. North America Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market
- 24.1. USA Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market Overview
- 24.2. USA Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market
- 25.1. Canada Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market Overview
- 25.2. Canada Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market
- 26.1. South America Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market Overview
- 26.2. South America Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market
- 27.1. Brazil Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market
- 28.1. Middle East Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market Overview
- 28.2. Middle East Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market
- 29.1. Africa Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market Overview
- 29.2. Africa Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market Competitive Landscape And Company Profiles
- 30.1. Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market Competitive Landscape
- 30.2. Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market Company Profiles
- 30.2.1. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Artiva Biotherapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Nkarta Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. ImmunityBio Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Fate Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
- 31. Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market Other Major And Innovative Companies
- 31.1. Acepodia Inc.
- 31.2. PersonGen BioTherapeutics Inc.
- 31.3. Cartherics Inc.
- 31.4. Century Therapeutics Inc.
- 31.5. Catamaran Bio Inc.
- 31.6. Glycostem Therapeutics Ltd.
- 31.7. ImmuneBridge Co. Ltd.
- 31.8. ONK Therapeutics Inc.
- 31.9. Senti Biosciences Inc.
- 31.10. Wugen Therapeutics Inc.
- 31.11. Chimeric Therapeutics Limited
- 31.12. East Ocyon Bio
- 31.13. Nuwacell Biotechnologies Co. Ltd.
- 31.14. Nkarta Therapeutics Inc.
- 31.15. GICELL Co. Ltd.
- 32. Global Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market
- 34. Recent Developments In The Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market
- 35. Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market High Potential Countries, Segments and Strategies
- 35.1 Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.